- Zeroing in on canine atopic dermatitis
- What makes dogs itch?
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
- Apoquel vs. Atopica: a comparison of two medications to control atopic dermatitis in dogs
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of 117 dogs with atopic dermatitis. Part 1: control of pruritus (itch).
Learn more about RESPIT
Subscribe to the SkinVet e-Newsletter!
Tag Archives: veterinary dermatology
By Jon Plant, DVM, DACVD Apoquel® (oclacitinib) is the new Zoetis drug for the treatment of atopic and allergic dermatitis in dogs at least 12 months of age. I’ve been prescribing Apoquel for almost 3 months now and I must … Continue reading
Allergen-specific immunotherapy (ASIT) is frequently used to manage canine atopic dermatitis (AD). The selection of allergens for ASIT is based on intradermal testing (IDT), allergen-specific immunoglobulin E (IgE) assays, patient history, and aerobiological data. In theory, an optimal allergenic extract … Continue reading
RESPIT, regionally-specific immunotherapy, is the practical allergy immunotherapy alternative that you can prescribe for atopic dermatitis in dogs and cats without allergy testing. I recently conducted a survey of all 160 veterinarians who had prescribed RESPIT Injectable prior to September … Continue reading
By Jon D. Plant, DVM, Dipl. ACVD Long before I developed regionally-specific immunotherapy (RESPIT), I was interested in studying the efficacy of allergen-specific immunotherapy (ASIT) in dogs. Why? The only placebo controlled study on ASIT, although a noble effort, had … Continue reading
by Jon Plant, DVM, DACVD Two routes of administration may be used for allergen immunotherapy: subcutaneous injection or oromucosal / sublingual. The subcutaneous route has been in use in humans and animals for more than 50 years. After an initial … Continue reading
With the rapid emergence of methicillin-resistant strains of Stapylococcus pseudintermedius (MRSP), the potential for nosocomial infections should be addressed by every veterinary hospital with a formal, written infection control program. Most of the control measures for MR staphylococci are applicable … Continue reading
An interesting study pertinent to RESPIT was brought to my attention by my friend Dr. Dean Gebroe of Culver City Animal Hospital. You may have noticed the capsule report in the September 2012 Clinician’s Brief entitled “One Allergen to Treat … Continue reading